期刊
PEDIATRIC BLOOD & CANCER
卷 62, 期 4, 页码 553-564出版社
WILEY-BLACKWELL
DOI: 10.1002/pbc.25313
关键词
brain; chemotherapy; pediatric hematology; oncology; tumours
资金
- Cancer Research UK [13457] Funding Source: researchfish
- The Brain Tumour Charity [16/193] Funding Source: researchfish
- Cancer Research UK [13457] Funding Source: Medline
Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3-5 years) according to the level of facilities available. Pediatr Blood Cancer 2015;62:553-564. (c) 2014 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据